I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Outcomes in Patients With Metastatic Renal Cell Carcinoma W..:
Bono, Petri
;
Oudard, Stephane
;
Bodrogi, Istvan
...
boreal:182656. , 2016
Link:
http://hdl.handle.net/2078.1/182656
RT Journal T1
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials
UL https://suche.suub.uni-bremen.de/peid=base-ftunistlouisbrus:oai:dial.uclouvain.be:boreal:182656&Exemplar=1&LAN=DE A1 Bono, Petri A1 Oudard, Stephane A1 Bodrogi, Istvan A1 Hutson, Thomas E A1 Escudier, Bernard A1 Machiels, Jean-Pascal A1 Thompson, John A A1 Figlin, Robert A A1 Ravaud, Alain A1 Basaran, Mert A1 Porta, Camillo A1 Bracarda, Sergio A1 Brechenmacher, Thomas A1 Lin, Chinjune A1 Voi, Maurizio A1 Grunwald, Viktor A1 Motzer, Robert J PB Cancer Information Group YR 2016 K1 Association of AEs and clinical efficacy K1 Class effects of mTOR inhibition K1 Targeted therapy K1 mTOR inhibitor JF boreal:182656 LK http://hdl.handle.net/2078.1/182656 DO http://hdl.handle.net/2078.1/182656 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)